International Stem Cell Corporation is currently running a Phase I clinical trial using human parthenogenetic stem cell-derived neural stem cells (ISC-hpNSC®). The company, through its wholly-owned Australian subsidiary, Cyto Therapeutics, is currently enrolling patients for the treatment of moderate to severe Parkinson’s disease in Melbourne, Victoria, Australia at the Department of Neurology of the Royal Melbourne Hospital.
If anyone participates please keep us posted!
I thought they already did the phase1 trial
This trial started I'm March 2018.. so too late now... this seems to be different study and not related to latest Japan trial of ips. No doubt findings will be published .think 1yr trial..
Phone call w/ Stem Cell Trial- Preclinical- 10 PWP ASAP. Participate in the preclinical to be first to have chance at phase 1 clinical. 
Aspen FINALLY Moving forward with Stem Cell Trials It seems to me that the Parkinson's research is almost zero What happened to the stem cell trials
Stem cell treatment Parkinson’s 
